A PILOT TRIAL OF RECOMBINANT HUMAN INTERLEUKIN-10 IN KIDNEY TRANSPLANT RECIPIENTS RECEIVING OKT3 INDUCTION THERAPY1,2-Reference-Cited by-同舟云学术

A PILOT TRIAL OF RECOMBINANT HUMAN INTERLEUKIN-10 IN KIDNEY TRANSPLANT RECIPIENTS RECEIVING OKT3 INDUCTION THERAPY1,2

Published:1997-10 Issue:7 Volume:64 Page:999-1006
ISSN:0041-1337
Container-title:Transplantation
language:en
Short-container-title:Transplantation

Author:

Wissing K. Martin,Morelon Emmanuel,Legendre Christophe,De Pauw Luc,LeBeaut Alexandre,Grint Paul,Maniscalki Margaret,Ickx Brigitte,Vereerstraeten Pierre,Chatenoud Lucienne,Kreis Henri,Goldman Michel,Abramowicz Daniel

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Transplantation

Reference52 articles.

1. Monoclonal Antibodies Defining Distinctive Human T Cell Surface Antigens

2. A Randomized Clinical Trial of OKT3 Monoclonal Antibody for Acute Rejection of Cadaveric Renal Transplants

3. A RANDOMIZED CLINICAL TRIAL OF INDUCTION THERAPY WITH OKT3 IN KIDNEY TRANSPLANTATION

4. EFFICACY OF REJECTION PROPHYLAXIS WITH OKT3 IN RENAL TRANSPLANTATION

5. OKT3 prophylaxis in renal grafts with prolonged cold ischemia times: Association with improvement in long-term survival

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. IL-10 Signaling Elicited by Nivolumab-Induced Activation of the MAP Kinase Pathway Does Not Fully Contribute to Nivolumab-Modulated Heterogeneous T Cell Responses;International Journal of Molecular Sciences;2021-10-31

2. Regulatory T Cell Therapy Following Liver Transplantation;Liver Transplantation;2020-12-23

3. The emerging role of regulatory T cells following lung transplantation;Immunological Reviews;2019-09-19

4. Fibrosis Related Inflammatory Mediators: Role of the IL-10 Cytokine Family;Mediators of Inflammation;2015

5. Muromonab-CD3 (Orthoclone OKT®3);Handbook of Therapeutic Antibodies;2014-08-12